3 High-Insider Growth Stocks To Watch On Euronext Paris

In This Article:

As the French CAC 40 Index recently added 0.48%, reflecting optimism around potential European Central Bank rate cuts and increased economic stimulus from China, investors are keenly observing growth opportunities within this market landscape. In such an environment, high-insider ownership can be a compelling factor for selecting growth stocks, as it often signals confidence from those closest to the company’s operations and strategic direction.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

20.6%

36%

VusionGroup (ENXTPA:VU)

13.4%

81.7%

Icape Holding (ENXTPA:ALICA)

30.2%

33.9%

Arcure (ENXTPA:ALCUR)

21.4%

26.6%

STIF Société anonyme (ENXTPA:ALSTI)

16.4%

22.9%

La Française de l'Energie (ENXTPA:FDE)

19.9%

31.9%

S.M.A.I.O (ENXTPA:ALSMA)

17.4%

35.2%

Adocia (ENXTPA:ADOC)

11.7%

64%

Munic (ENXTPA:ALMUN)

27.1%

174.1%

MedinCell (ENXTPA:MEDCL)

15.8%

93.9%

Click here to see the full list of 23 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Exclusive Networks

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Exclusive Networks SA is a global cybersecurity specialist focused on digital infrastructure, with a market cap of €2.14 billion.

Operations: The company generates revenue from its operations across three primary regions: €480 million from APAC, €4.19 billion from EMEA, and €705 million from the Americas.

Insider Ownership: 13.1%

Exclusive Networks, a cybersecurity firm in France, is undergoing significant changes as private equity firms Clayton, Dubilier & Rice and Permira plan to take it private in a €2.2 billion deal. Currently 66.7% owned by Permira and founder Olivier Breittmayer, the transaction offers a 34.4% premium on its share price and includes an exceptional distribution of €5.29 per share. Despite lower profit margins recently, earnings are expected to grow significantly above market rates over the next few years.

ENXTPA:EXN Ownership Breakdown as at Oct 2024
ENXTPA:EXN Ownership Breakdown as at Oct 2024

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a pharmaceutical company based in France that specializes in developing long-acting injectables across various therapeutic areas, with a market cap of €465.98 million.

Operations: The company's revenue segment is derived entirely from its Pharmaceuticals division, amounting to €11.95 million.